Delta Financial Advisors’s Novartis NVS Stock Holding History

Delta Financial Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,681	Closed	-$818K	–	113
2022 Q2	$818K	Sell	9,681 -255	-3%	-$22.4K	0.41%	79
2022 Q1	$872K	Hold	9,936	–	–	0.37%	78
2021 Q4	$869K	Hold	9,936	–	–	0.35%	78
2021 Q3	$813K	Hold	9,936	–	–	0.36%	81
2021 Q2	$907K	Hold	9,936	–	–	0.4%	76
2021 Q1	$849K	Hold	9,936	–	–	0.4%	79
2020 Q4	$938K	Hold	9,936	–	–	0.47%	70
2020 Q3	$864K	Sell	9,936 -125	-1%	-$10.8K	0.48%	70
2020 Q2	$879K	Hold	10,061	–	–	0.52%	69
2020 Q1	$830K	Sell	10,061 -390	-4%	-$34.8K	0.57%	65
2019 Q4	$990K	Sell	10,451 -35	-0.3%	-$3.14K	0.39%	75
2019 Q3	$911K	Hold	10,486	–	–	0.37%	84
2019 Q2	$957K	Buy	+10,486	New	+$887K	0.4%	81

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Delta Financial Advisors's NVS Position: Q3 2022 in Review

Delta Financial Advisors sold out of Novartis (NVS) in Q3 2022, closing a stake of 9,681 shares — an estimated $818K sold.

Delta Financial Advisors first reported a position in NVS in Q2 2019 and held it in 13 quarters. The position peaked at $990K in Q4 2019. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

Delta Financial Advisors reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
Delta Financial Advisors sold 9,681 Novartis shares in Q3 2022, an estimated $818K.
Delta Financial Advisors first reported a position in Novartis in Q2 2019 and held it in 13 quarters.
Delta Financial Advisors's Novartis position peaked at $990K in Q4 2019.
1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on Delta Financial Advisors's 13F filing for Q3 2022, filed 27 Oct 2022.